Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103)
National Cancer Institute (NCI)
Kathy D Miller; Anne O'Neill; William Gradishar; Timothy J Hobday; Lori J Goldstein; Ingrid A Mayer; Stuart Bloom; Adam M Brufsky; Amye J Tevaarwerk; Joseph A Sparano; Nguyet Anh Le-Lindqwister; Carolyn B Hendricks; Donald W Northfelt; Chau T Dang; George W Sledge